Table 1 |
|||
|
Frequency and mean level of anti-Ro-52 in patients tested |
|||
| Antibody Group |
Number of patients |
Anti-Ro-52 positive (%) |
Mean anti-Ro52 level (U/ml) |
|
|
|||
| ACA |
197 |
28 |
22 |
|
|
|||
| AFA |
48 |
15 |
18 |
|
|
|||
| ARA |
207 |
25 |
22 |
|
|
|||
| ATA |
210 |
19 |
22 |
|
|
|||
| fsnu |
44 |
32 |
26 |
|
|
|||
| Anti-aats |
6 |
100 |
109 |
|
|
|||
| Anti-Ku |
5 |
60 |
49 |
|
|
|||
| NDA |
173 |
28 |
31 |
|
|
|||
| Anti-Pm-Scl |
49 |
33 |
34 |
|
|
|||
| Anti-U1-RNP |
58 |
38 |
50 |
|
|
|||
| Anti-Ro-60 |
13 |
92 |
121 |
|
|
|||
| Total SSc |
1010 |
27 |
28 |
|
|
|||
| Anti-aats (non-SSc) |
55 |
64 |
78 |
|
|
|||
| Anti-Ku (non-SSc) |
32 |
28 |
33 |
|
|
|||
|
Parker et al. Journal of Autoimmune Diseases 2009 6:2 doi:10.1186/1740-2557-6-2 |
|||
